Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management

Ghassan K. Abou-Alfa; Larry Norton; The Global Oncology Medical Diplomacy Working Group

doi:10.5334/aogh.3967

Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management

Annals of Global Health

Volume 89 (2023): Issue 1

By: Ghassan K. Abou-Alfa , Larry Norton and The Global Oncology Medical Diplomacy Working Group

Open Access

|Feb 2023

Abstract

We convened an international working group to examine the issues that challenge equity and inclusion in genetic medicine. Specifically, 72 internationally known experts in oncology and cancer genetics from 34 countries (the Global Oncology Medical Diplomacy Working Group), gathered virtually on January 4–5, 2022, for the “Humanity Cancer Germline Convergence and Divergence Cancer Predispositions” conference hosted by Memorial Sloan Kettering Cancer Center, in collaboration with the United Arab Emirates Ministry of Health and the Al Jalila Foundation. The goal of the conference was to broaden transnational understanding of the current state of genetics in preventive and therapeutic cancer medicine, and to define barriers to increased uptake of germline genomics to decrease the international burden of cancer. Here, we highlight the overarching barriers that were defined through this effort. These global barriers to incorporating germline genomics into optimal cancer care can inform ongoing research, collaboration, and advocacy for equitable, cost-effective genomic medicine for populations worldwide.

References

Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Science Translational Medicine. 2012; 4(127): 127rv124. DOI: 10.1126/scitranslmed.3003218
Open DOI Search in Google Scholar Back to article
Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins: Genetic and nongenetic familial risk factors. J Natl Cancer Inst. 1997; 89(4): 287–293. DOI: 10.1093/jnci/89.4.287
Open DOI Search in Google Scholar Back to article
Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2): 78–85. DOI: 10.1056/NEJM200007133430201
Open DOI Search in Google Scholar Back to article
Cortes J, Perez-Garcia JM, Llombart-Cussac A, et al. Enhancing global access to cancer medicines. CA Cancer J Clin. 2020; 70(2): 105–124. DOI: 10.3322/caac.21597
Open DOI Search in Google Scholar Back to article
Offit K. Decade in review—genomics: A decade of discovery in cancer genomics. Nature Reviews Clinical Oncology. 2014; 11(11): 632–634. DOI: 10.1038/nrclinonc.2014.170
Open DOI Search in Google Scholar Back to article
Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: Setting paradigms in personalized cancer care and prevention. Science. 2014; 343(6178): 1466–1470. DOI: 10.1126/science.1251827
Open DOI Search in Google Scholar Back to article
Mandelker D, Zhang L, Kemel Y, et al. Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA. 2017; 318(9): 825–835. DOI: 10.1001/jama.2017.11137
Open DOI Search in Google Scholar Back to article
Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002; 346(21): 1609–15. DOI: 10.1056/NEJMoa020119
Open DOI Search in Google Scholar Back to article
Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin JP. Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009; 27(28): 4793–7. DOI: 10.1200/JCO.2009.23.7784
Open DOI Search in Google Scholar Back to article
Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP, et al. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: A double-blind, randomised, placebo-controlled trial. Lancet. 2020; 395(10240): 1855–1863. DOI: 10.1016/S0140-6736(20)30366-4
Open DOI Search in Google Scholar Back to article
Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E, et al. Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol. 2021; 39(24): 2698–2709. DOI: 10.1200/JCO.20.03661
Open DOI Search in Google Scholar Back to article
Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019; 37(15): 1305–1315. DOI: 10.1200/JCO.18.01854
Open DOI Search in Google Scholar Back to article
Williams CD, Bullard AJ, O’Leary M, Thomas R, Redding TS, 4th, Goldstein K. Racial/ethnic disparities in BRCA counseling and testing: A narrative review. J Racial Ethn Health Disparities. 2019; 6(3): 570–583. DOI: 10.1007/s40615-018-00556-7
Open DOI Search in Google Scholar Back to article
Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, et al. Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: Implications for health care inequities. JCO Precis Oncol. 2021; 5: PO.21.00233. DOI: 10.1200/PO.21.00233
Open DOI Search in Google Scholar Back to article
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. J Natl Compr Canc Netw. 2021; 19(1): 77–102.
Search in Google Scholar Back to article
Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007; 25: 3985–3990. DOI: 10.1200/JCO.2007.12.2622
Open DOI Search in Google Scholar Back to article
Feitosa J, das Chagas PF, de Sousa GR, et al. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors. Mol Biol Rep. 2020; 47(8): 6439–6443. DOI: 10.1007/s11033-020-05655-5
Open DOI Search in Google Scholar Back to article
Cline MS, Liao RG, Parsons MT, et al. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018; 14(12): e1007752. DOI: 10.1371/journal.pgen.1007752
Open DOI Search in Google Scholar Back to article
Toland AE, Forman A, Couch FJ, et al. Clinical testing of BRCA1 and BRCA2: A worldwide snapshot of technological practices. NPJ Genom Med. 2018; 3: 7. DOI: 10.1038/s41525-018-0046-7
Open DOI Search in Google Scholar Back to article
Wauters A, Van Hoyweghen I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016; 61(4): 275–282. DOI: 10.1038/jhg.2015.151
Open DOI Search in Google Scholar Back to article
Otlowski M, Taylor S, Bombard Y. Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet. 2012; 13: 433–454. DOI: 10.1146/annurev-genom-090711-163800
Open DOI Search in Google Scholar Back to article
Abacan M, Alsubaie L, Barlow-Stewart K, et al. The Global State of the Genetic Counseling Profession. Eur J Hum Genet. 2019; 27(2): 183–197. DOI: 10.1038/s41431-018-0252-x
Open DOI Search in Google Scholar Back to article
Berninger T, Nusbaum R, Redlinger-Grosse K, Davis C, Reiser C. A narrative literature review: Growing the workforce through increased fieldwork capacity in genetic counseling training programs. J Genet Couns. 2021; 30(2): 574–587. DOI: 10.1002/jgc4.1346
Open DOI Search in Google Scholar Back to article
Bertagnolli MM, Sartor O, Chabner BA, et al. Advantages of a truly open-access data-sharing model. N Engl J Med. 2017; 376(12): 1178–1181. DOI: 10.1056/NEJMsb1702054
Open DOI Search in Google Scholar Back to article
Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401–404. DOI: 10.1158/2159-8290.CD-12-0095
Open DOI Search in Google Scholar Back to article
Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): l1. DOI: 10.1126/scisignal.2004088
Open DOI Search in Google Scholar Back to article
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020; 383(7): 640–649. DOI: 10.1056/NEJMoa1916623
Open DOI Search in Google Scholar Back to article
Sudlow C, Gallacher J, Allen N, et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12(3): e1001779. DOI: 10.1371/journal.pmed.1001779
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.5334/aogh.3967 | Journal eISSN: 2214-9996

Journal RSS Feed

Language: English

Submitted on: Sep 17, 2022

Accepted on: Dec 22, 2022

Published on: Feb 21, 2023

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

cancer,

© 2023 Ghassan K. Abou-Alfa, Larry Norton, The Global Oncology Medical Diplomacy Working Group, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 89 (2023): Issue 1